TuHURA Biosciences (HURA) Payables (2011 - 2026)

TuHURA Biosciences' Payables history runs 16 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Payables rose 28.21% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 28.21% YoY), while the FY2025 annual figure was $3.8 million, down 27.08% from the prior year.
• Payables for Q1 2026 stood at $4.0 million, up from $3.8 million in the prior quarter.
• The five-year high for Payables was $12.5 million in Q2 2025, with the low at $1.2 million in Q1 2024.
• The 5-year median for Payables is $3.0 million (2023), against an average of $3.7 million.
• The sharpest annual moves came in 2024 and 2025: Payables sank 52.38% in 2024, then surged 467.61% in 2025.
• TuHURA Biosciences' Payables stood at $2.7 million in 2022, then soared by 32.87% to $3.6 million in 2023, then soared by 44.6% to $5.2 million in 2024, then retreated by 27.08% to $3.8 million in 2025, then climbed by 4.88% to $4.0 million in 2026.
• Business Quant data shows HURA's Payables at $4.0 million in Q1 2026, $3.8 million in Q4 2025, and $6.0 million in Q3 2025.